Abstract
Introduction
Bladder cancer is the 7th most common cancer in the Western world [1] . Despite no consistent evidence for the superiority of radical cystectomy over radiotherapy [2] cystectomy is often the treatment of choice in younger, fitter patients [3] . Primary radiotherapy is generally offered to older patients or those with significant comorbidity.
Radiotherapy alone offers initial complete response rates of the order of 75 % but in the longer term sustained local control is only achieved in 30 -50 % [4, 5] .
The bladder is subject to significant organ motion over the course of radiation delivery and geographical miss may contribute to reduced local control and subsequent survival. A standard margin of the order of 15 -20 mm is added around the bladder to account for organ motion and set-up error. These standard margins may be inadequate with the percentage of patients observed with a partial geometric miss at least once during a treatment course ranging from 19 to 65% [6] [7] [8] .
Image guided radiotherapy (IGRT) is likely to be of significant benefit in bladder treatments both to reduce the risk of geographical miss and minimise treatment related bowel toxicity. Volumetric bladder imaging using cone beam CT provides images of ample quality for use in IGRT [9, 10] . The National Radiotherapy Implementation Group (NRIG) published guidelines for IGRT implementation and use in 2012 [11] . This work considers the impact of the routine introduction of an offline kV CBCT based IGRT protocol in bladder radiotherapy patients, in terms of rate of replanning, isocentre correction and clinical intervention. Furthermore, cancer outcomes are presented in terms of cystoscopic response rates and both overall and bladder cancer specific survival.
Materials and Methods
A retrospective review of IGRT prospectively recorded data of 141 non-metastatic bladder cancer patients consecutively treated from March 2007 to July 2010 was undertaken. All patients were treated with 3DCRT and volumetric IGRT with curative intent.
Treatment planning and delivery
All patients were treated in the head-first supine position with a knee rest but no other formal immobilisation. Patients were instructed to empty the bladder immediately prior to CT scanning and no drinking protocol was used. For patients with node-negative disease, the CTV was defined as the whole bladder including any extra-capsular spread. Isotropic margins of 1.5 -2.0 cm were then added to generate the PTV. For patients with node-positive disease, the whole pelvis was treated with a phase 2 boost to the bladder with a 1.5 cm margin. A standard conformal 3 or 4 field technique was used.
In patients undergoing bladder-only treatment, a dose of 52.5 -55.0 Gy was prescribed to 100%, with the PTV encompassed by the 95% isodose Treatment was delivered in 20 daily fractions over 28 days (treatment was delivered Monday Friday only). In those undergoing additional whole pelvis treatments, 40-46 Gy was delivered to the whole pelvis followed by a phase 2 treatment to the bladder, delivering a total dose of 60-66 Gy in 2 Gy per fraction.
Treatment verification with IGRT
IGRT was performed using a kV CBCT system (XVI, Version 4.2 (2007 Version 4.2 ( -2010 , Elekta AB, Stockholm, Sweden) equipped on a linear accelerator (Elekta Synergy (2007 -2010 , Elekta AB, Stockholm, Sweden). CBCTs were acquired on the day before the first treatment delivery day, to verify positioning and readiness prior to treatment, and on the first two treatment days. All images were reviewed online and corrective action implemented immediately for gross errors (>1 cm) and reviewed offline to identify and correct for systematic errors. Image matching was performed through an initial automatic bony alignment of the CBCT to the reference CT scan, followed by a manual alignment of the CTV (bladder). These first three images were analysed in an offline setting and any systematic errors in bladder position > 3 mm or more than 5 degrees corrected for by an adjustment of isocentre position for subsequent fractions. The patient was then imaged weekly. Additional kV CBCT was required for patients displaying daily random error and also after the application of any isocentre correction. Megavoltage (MV) portal imaging was not performed.
Imaging review and interventions were radiographer led, with the involvement of medical physics and/or the prescribing clinician where appropriate. Image analysis was undertaken independently by 2 radiographers from a pool of staff who had all undergone training and competency assessment in bladder IGRT using CBCT.
IGRT interventions
A number of interventions were undertaken. Isocentre shifts were used to correct for systematic bony SUE and/or small systematic changes in bladder position, shape or volume relative to surrounding bony anatomy. Repeat CT scanning was used when systematic changes in bladder volume or shape were found to result in the 15-20 mm bladder to PTV margin providing either inadequate bladder coverage, or excessive dose to organs at risk. Other clinical interventions identified as a result of CBCT were recorded, such as catheterisation or regular laxatives used, with the aim to reduce the effect of organ volume changes and/or improve CTV coverage.
Population bone setup errors
Automatic bone matching software was used to generate displacements and rotations in RightLeft, Superior-Inferior and Anterior-Posterior directions for each CBCT. The systematic and random components of bone error were calculated using the method described in BIR publication, 
Population bladder organ motion
Manual soft tissue matching was implemented by matching CTV (bladder) on the CBCT to the planning CT therefore the shifts were used a surrogate of bladder motion at time of treatment compared to simulation. Population bladder organ motion data were generated in the Right-Left, Superior-Inferior and Anterior-Posterior directions. The bladder was not re-contoured on any images.
Statistics
Positioning errors are analysed using simple descriptive statistics. Kaplan-Meier curves were produced for overall and bladder cancer specific survival using SPSS version 21 (IBM Corporation, New York, USA).
Results

Patient characteristics and clinical outcomes
The patient group was heterogeneous (Table 1) For the 63 patients demonstrating soft tissue deformations, 12 patients would have received a much greater dose to small bowel had it not been for the use of IGRT, whereas the remaining 51 patients would have received inadequate dose to the target volume due to partial geometric miss.
Changes in bladder or rectal volume, shape or position were the source of soft tissue deformations with 10% of patients demonstrating a smaller rectal volume, 4% with an increased rectal volume, 9% with a reduced bladder volume, and 38% with an increased bladder volume. These soft tissue deformations were observed at the start of treatment in the vast majority of patients. 88% of problems were identified at the first CBCT, and confirmed as consistent over subsequent days.
Only 12% of problems were identified during weekly review after the first week of treatment.
Population Bone Set-up errors
Population systematic and random bone setup errors measured by automatic matching from CBCT were all in the range 1-3 mm and < 1.5° (Table 3) demonstrating consistent patient positioning in line with published recommendations [13, 14] .
Population bladder organ motion errors
Organ motion was observed to be greatest in the Superior-Inferior direction in which 61% of patients exhibited organ motion of > 5 mm for at least one fraction imaged (Table 4 Without IGRT, the use of population margins of 1.5 -2 cm from CTV to PTV can be either inadequate or excessive for individual patients. Recognising that population data for CTV -PTV margins do not always provide the best treatment for a given individual, adaptive radiotherapy (ART) may be a good option for bladder radiotherapy [9] . ART uses either multiple CTs or CBCTs acquired over initial treatments, to assess random and systematic error for that individual and then produce an adapted plan with a PTV designed to encompass the target volume on all scans.
Our work suggests that ART may benefit the 28% of patients who demonstrated soft tissue changes that could be encompassed with an isocentre shift. However, the isocentre shift was effective without the additional work needed for ART. 28% of patients in this review do demonstrate gross changes in target volume on the first verification image. For these patients, A approach may be more effective. Patients can be planned with treatments to encompass small, medium and large bladder volumes. After CBCT acquisition, the most appropriate plan from the library can be chosen for that day. This would also be effective for the 4% patients who demonstrate large changes resulting in repeat CT planning at some point after the first week of treatment.
T i.e. any intervention during treatment delivery that improves accuracy of treatment delivery. More technical adaptive ches, have been adopted in other, smaller bladder cancer patients series, and have been shown to be feasible and to result in a smaller volume of normal tissue irradiation as well as improvements in target coverage [8, 9, 15, 16] . Intuitively such strategies should result in improved local control and overall survival. This is the subject of clinical trials. In the HYBRID trial palliative patients are randomised between standard radiotherapy using the same plan for each fraction, or an adaptive strategy where the best of three possible plans (small, medium and large bladder volumes) are selected on each treatment day [17] . In the radical setting the RAIDER trial will investigate adaptive strategies by randomising patients between standard radiotherapy using one plan, an adaptive approach which selects one of three (small, medium and large) plans for each treatment and an adaptive approach which also delivers escalated doses to the whole bladder and tumour [18] .
Similar to prostate radiotherapy patients, this work demonstrates that rectal filling impacts on bladder positioning [10, 9] . Intervention such as the use of daily enemas may result in more consistent positioning in these patients [20] . Changes in our practice include the introduction of a crude assessment of rectal volume and intervention if a maximum rectal diameter at CT planning of 5 cm adjacent to the bladder is noted.
A small proportion of our patients underwent neo-adjuvant chemotherapy. Subsequently BC2001, a large phase 3 RCT, has demonstrated an improvement in two-year disease free survival from 54% to 67% with the addition of concurrent chemotherapy to radical radiotherapy [21] and this is now our standard practice in suitable patients. Volumetric IGRT was not available when the BC2001 trial recruited and increased toxicity was noted during treatment in the group undergoing concurrent chemotherapy. It would be likely that the routine use of volumetric IGRT would reduce treatment toxicity when concurrent chemotherapy is delivered.
T IG'T ated toxicity and local control. We would expect IGRT to reduce radiation related bowel toxicity and improve local bladder cancer control. We currently lack randomised trial evidence to quantify the impact of IGRT and adaptive treatments in bladder cancer. The overarching principle of radiotherapy is to treat the target consistently with minimal dose to adjacent OAR. Volumetric IGRT achieves this but is more labour intensive and the optimal imaging strategy is yet to be defined.
Conclusions
Organ deformation during radiotherapy for bladder cancer can be significant and places the patient at risk of geographical miss or excessive normal tissue irradiation. Strategies to monitor and compensate for deformation, including volumetric imaging, shifts, adaptive radiotherapy techniques and an openness to re-planning if necessary, are essential to ensure optimal plan delivery. Modern phase III radiotherapy trials will investigate the ultimate impact of such adaptive approaches on bladder cancer toxicity and survival outcomes. 
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